Transfusion independence and survival in patients with acute myeloid leukemia treated with 5-azacytidine

被引：24
|
作者：
Gavillet, Mathilde [1 ]
Noetzli, Jasmine [1 ]
Blum, Sabine [1 ]
Duchosal, Michel A. [1 ]
Spertini, Olivier [1 ]
Lambert, Jean-Francois [1 ]
机构：
[1] Univ Lausanne Hosp, Serv & Cent Lab Hematol, CH-1011 Lausanne, Switzerland
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2012年 / 97卷 / 12期
关键词：
5-azacytidine; acute myeloid leukemia; transfusion independence; survival; CONVENTIONAL CARE REGIMENS; LOW-DOSE CYTARABINE; MYELODYSPLASTIC SYNDROMES; AZACITIDINE; TRIALS;
D O I：
10.3324/haematol.2012.065151
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1929 / 1931
页数：3
相关论文
共 50 条
  • [21] 5-Azacytidine-Mediated Modulation of the Immune Microenvironment in Murine Acute Myeloid Leukemia
    Ebelt, Nancy D.
    Manuel, Edwin R.
    CANCERS, 2023, 15 (01)
  • [22] Pilot study of combination transcriptional modulation therapy with sodium phenylbutyrate and 5-azacytidine in patients with acute myeloid leukemia or myelodysplastic syndrome
    Maslak, P
    Chanel, S
    Camacho, LH
    Soignet, S
    Pandolfi, P
    Guernah, I
    Warrell, R
    Nimer, S
    LEUKEMIA, 2006, 20 (02) : 212 - 217
  • [23] Successful 5-azacytidine treatment of myeloid sarcoma and leukemia cutis associated with myelodysplastic syndrome A case report and literature review
    Katagiri, Takayuki
    Ushiki, Takashi
    Masuko, Masayoshi
    Tanaka, Tomoyuki
    Miyakoshi, Shukuko
    Fuse, Kyoko
    Shibasaki, Yasuhiko
    Takizawa, Jun
    Aoki, Sadao
    Sone, Hirohito
    MEDICINE, 2017, 96 (36)
  • [24] Prognostic impact of the number of methylated genes in myelodysplastic syndromes and acute myeloid leukemias treated with azacytidine
    Abaigar, Maria
    Ramos, Fernando
    Benito, Rocio
    Diez-Campelo, Maria
    Sanchez-del-Real, Javier
    Hermosin, Lourdes
    Nicolas Rodriguez, Juan
    Aguilar, Carlos
    Recio, Isabel
    Maria Alonso, Jose
    de las Heras, Natalia
    Megido, Marta
    Fuertes, Marta
    Consuelo del Canizo, Maria
    Maria Hernandez-Rivas, Jesus
    ANNALS OF HEMATOLOGY, 2013, 92 (11) : 1543 - 1552
  • [25] Teriflunomide restores 5-azacytidine sensitivity via activation of pyrimidine salvage in 5-azacytidine-resistant leukemia cells
    Imanishi, Satoshi
    Takahashi, Ryoko
    Katagiri, Seiichiro
    Kobayashi, Chiaki
    Umezu, Tomohiro
    Ohyashiki, Kazuma
    Ohyashiki, Junko H.
    ONCOTARGET, 2017, 8 (41) : 69906 - 69915
  • [26] Treatment of poor-risk myelodysplastic syndromes and acute myeloid leukemia with a combination of 5-azacytidine and valproic acid
    Andrea Kuendgen
    Gesine Bug
    Oliver G. Ottmann
    Detlef Haase
    Julie Schanz
    Barbara Hildebrandt
    Kathrin Nachtkamp
    Judith Neukirchen
    Ariane Dienst
    Rainer Haas
    Ulrich Germing
    Norbert Gattermann
    Clinical Epigenetics, 2011, 2 : 389 - 399
  • [27] SUMOylation inhibitor TAK-981 (subasumstat) synergizes with 5-azacytidine in preclinical models of acute myeloid leukemia
    Gabellier, Ludovic
    De Toledo, Marion
    Chakraborty, Mehuli
    Akl, Dana
    Hallal, Rawan
    Aqrouq, Mays
    Buonocore, Giovanni
    Recasens-Zorzo, Clara
    Cartron, Guillaume
    Delort, Abigail
    Piechaczyk, Marc
    Tempe, Denis
    Bossis, Guillaume
    HAEMATOLOGICA, 2024, 109 (01) : 98 - 114
  • [28] 5-Azacytidine in the Treatment of Intermediate-2 and High-risk Myelodysplastic Syndromes and Acute Myeloid Leukemia. A Five-year Experience with 44 Consecutive Patients
    Diamantopoulos, Panagiotis
    Zervakis, Konstantinos
    Papadopoulou, Vasiliki
    Iliakis, Theodoros
    Kalala, Fani
    Giannakopoulou, Nefeli
    Rougala, Niki
    Galanopoulos, Athanassios
    Bakarakos, Panagiotis
    Variami, Eleni
    Dimitrakopoulou, Aglaia
    Viniou, Nora-Athina
    ANTICANCER RESEARCH, 2015, 35 (09) : 5141 - 5147
  • [29] Is it time for 5-azacytidine combinations in high-risk myelodysplastic syndrome patients?
    Park, Sophie
    EXPERT REVIEW OF HEMATOLOGY, 2013, 6 (01) : 39 - 42
  • [30] Treatment of poor-risk myelodysplastic syndromes and acute myeloid leukemia with a combination of 5-azacytidine and valproic acid
    Kuendgen, Andrea
    Bug, Gesine
    Ottmann, Oliver G.
    Haase, Detlef
    Schanz, Julie
    Hildebrandt, Barbara
    Nachtkamp, Kathrin
    Neukirchen, Judith
    Dienst, Ariane
    Haas, Rainer
    Germing, Ulrich
    Gattermann, Norbert
    CLINICAL EPIGENETICS, 2011, 2 : 389 - 399
12345